The Swiss multinational manufacturing firm Lonza (SWX:LONN) has bolstered its particle engineering services available at its site in Monteggio, Switzerland.
In particular, the new site will offer X-ray powder diffraction (XRPD) services.
XRPD is a rapid analytical technique that offers insight into the polymorph and solid-state properties of active pharmaceutical ingredients (APIs).
Lonza employees at the Monteggio site will use various analytical techniques to study the solid state of crystalline materials.
“The implementation of XRPD provides additional analytical information, highlighting differences in the solid state of materials before and after micronization, and determining whether additional processing is needed,” said Salvatore Mercuri, associate director, new product introduction and MSAT, in a statement. “The XRPD improves our ability to detect solid state changes induced by the micronization process early in development and allows the…